Butterfly Medical – develops an innovative, implantable device for the treatment of Benign Prostatic Hyperplasia (BPH).
The Butterfly Medical device is a new generation device that offers a superior alternative to existing BPH minimally invasive treatments.

Butterfly is an investigational device in the USA, Limited by Federal (or United States) law to investigational use

watch our video
Non surgical
Permanent solution
10 minute procedure
Office based procedure
Local Anesthesia

Great early results in clinical trials

  • Fast and simple delivery
  • Good dilation of the prostate urethra
  • Good voiding by patients and no side effects

Interview with a Butterfly patient

What is BPH?

BPH is the non-cancerous enlargement of the prostate, effecting affecting 50% of men above 60 and more than 70% of men above 70.
BPH symptoms have a significant effect on the quality of life.

Approximately 30 million men around the world experience some level of BPH symptoms and about 25% of those men will actively seek treatment.


Idan Geva

Idan brings more than 12 year of commercial and business experience in the medical device industry.
Portfolio includes: FlowMedic (CEO), Abbott Vascular (marketing), MCS (marketing), Biotronik (sales)
Idan holds a BSc. in engineering and an MBA

Shimon Eckhouse
Investor and Chairman

One of Israel’s leading medical entrepreneurs.
Founded and invested in more than 20 startups.
Portfolio includes: Lumenis, Syneron, Rapid Medical, Tulip, RealView, Ventor

Adrian Paz
MD, CMO and Co-Founder

Adrian is a certified urologist with deep understanding of the BPH market.
A serial entrepreneur, Adrian brings years of experience in developing innovative medical technologies.
Portfolio includes: EON Surgical, Orthospace, Vibrant, Clip-Tip Medical, Saturix, Stepwise

Yehuda Bachar

Yehuda is a mechanical engineer and a serial entrepreneur, bringing many years of experience in developing medical technologies
Portfolio includes: Clip-Tip Medical, Saturix, EON Surgical, SteadyMed.
Yehuda holds a BSc. in mechanical engineering

Vardit Segal
VP Clinical and Regulatory Affairs

Vardit brings more than 15 years of experience in clinical and regulatory leadership positions, leading clinical and regulatory efforts in the US and various other countries.
Vardit holds a PhD in Biomedical Engineering

Steffen Hovard
Board Member

Over the last 20 years, Mr. Hovard has held multiple leadership roles at subsidiaries of Coloplast, a publicly-traded global medical device company. Most recently, he served as the President of Interventional Urology from 2011 to 2019. At Interventional Urology, Mr. Hovard operated in a CEO capacity leading approximately 900 employees across corporate development with complete oversight of R&D, operations/manufacturing, marketing, sales, human resources, finance and legal


Butterfly Medical receives IDE approval from FDA to start US Pivotal Trial

The FDA concluded that sufficient data was provided to support activation of a human clinical study in the US. The decision was based on the total evidence provided, including clinical data from the ongoing “first in man” study in Israel, which verified our early safety and performance outcomes.

Butterfly Medical Receives CE Mark

Butterfly Medical receives CE Approval for its next generation medical device to noninvasively treat men suffering from BPH symptoms




1st Place in MassChallenge Israel 2019

Butterfly Medical was nominated Diamond Winner in the 2019 MassChallenge Israel cohort.






Butterfly Medical’s Clinical Trial in Israel

Butterfly Medical’s multicentral trial was launched in Israel in November 2018. So far, 50 patients were successfully treated to improve BPH symptoms and enrollment is in progress in 4 medical centers: Ziv (Safed), Rabin (Petach Tikva), Carmel (Haifa) and Shamir (Be’er Ya’akov).

Please contact us at: info@butterfly-medical.com to receive further information about the ongoing trial.

    למידע בעברית על הניסוי הקליני בארץ www.butterflymedical.co.il 


Future Events

EAU Conference, Amsterdam, The Netherlands, March 18-21, 2022

Butterfly Medical’s CEO will be attending the EAU Conference .
To schedule a meeting please contact: info@butterfly-medical.com

Previous Events

AUA Conference, September 2021, Virtual- Presentation of Butterfly Medical clinical outcomes

EAU Conference, July 2021, Virtual- Presentation of Butterfly Medical clinical outcomes

EAU Conference, March 2019, Barcelona, Spain

Medica Exhibition, November 2018, Dusseldorf, Germany

DGU National Meeting, September 2018, Dresden, Germany

Contact Us

Butterfly Medical
Beit Tavor 2nd entrance, 3rd floor, Yokneam 20692, Israel





    Accessibility Toolbar